Aortic Stenosis Market Analysis, Opportunities & Trends 2031

Aortic Stenosis Market Analysis, Opportunities & Trends 2031

Segments - Aortic Stenosis Market by Type (Congenital [Subvalvular, Valvular, and Supravalvular] and Acquired), Treatment (Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement), Treatment Center (Pharmacy Stores, Clinics, and Hospitals), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-5009 | 4.1 Rating | 68 Reviews | 174 Pages | Format : PDF Excel PPT

Report Description


The global aortic stenosis market size was valued at nearly USD 5.4 Billion in 2022 and is expected to reach USD 12.6 Billion by 2031, expanding at a CAGR of 9.8% during the forecast period, 2023 – 2031. The growth of the market is attributed to the growing numbers of aortic stenosis and valvular heart diseases in the geriatric population.

Aortic stenosis is a valvular heart disease with varying severity. Narrowed valve openings of the large blood vessel aorta reduce blow flow making the heart pump excessively. Poor prognosis with a fatal mortality rate is observed in severe cases. In-time diagnosis and treatment are of significant importance.

Aortic Stenosis Market Outlook

Congenital heart defects, rheumatic fever, and the building up of excess calcium in the heart valves are some of the known causes of aortic stenosis. Chest pain, fainting, fatigue, abnormal heart beats, and sound are commonly observed symptoms. Heart attack diagnostics is a suitable method to check for heart abnormalities.

The market report finds that the COVID-19 pandemic adversely affected the aortic stenosis market growth with sudden government-imposed lockdowns around the world. There was a large decline in Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) procedural activity for treating severe aortic stenosis cases during the COVID-19 pandemic.

Major Drivers

Growing geriatric population with heart valve abnormalities is driving the market growth of the aortic stenosis market. Health complications involving severe diabetes and obesity are major causes for an increased number of aortic stenosis patients. Extensive research and innovation of effective drugs to counter the disease are expected to bolster the aortic market development in the near future.

Existing Restraints

High treatment costs and complex treatment procedures are likely to restrain market growth in the coming years. Reactive nature of treatments available is a major hindrance for the widespread expansion of the aortic stenosis market.

Emerging Opportunities

Improving healthcare facilities and introducing of innovative healing methods are providing growth opportunities for market expansion. Growing adoption of initiatives for spreading awareness about treatments, symptoms, and causes of aortic stenosis coupled with investments in healthcare are expected to increase market development opportunities for the aortic stenosis market in the forecast period.

Aortic Stenosis Market Dynamics

Scope of Aortic Stenosis Market Report

The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Aortic Stenosis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2020 – 2021

Forecast Period

2023–2031

Segmentation

Type (Congenital [Subvalvular, Valvular, and Supravalvular] and Acquired), Treatment (Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement), and Treatment Center (Pharmacy Stores, Clinics, and Hospitals)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boston Scientific Corporation; CryoLife, Inc.; JenaValve Technology, Inc.; Thubrikar Aortic Valve; Medtronic plc; Coroneo Meril Life Sciences Pvt. Ltd.; AstraZeneca plc.; Abbott Laboratories; LivaNova PLC; Edwards Lifesciences Corporation; and LifeNet Health.

Aortic Stenosis Market Segment Insights

Type Segment Analysis

Based on the type, the aortic stenosis market is bifurcated into congenital aortic stenosis and acquired aortic stenosis. The congenital aortic stenosis segment is projected to hold a considerable CAGR during the forecast period, due to the presence of abnormalities in children by birth due to genetically induced conditions.

The congenital aortic stenosis segment is further subclassified based on the level of stenosis, into subvalvular aortic stenosis, valvular, and supravalvular aortic stenosis, and is known to develop during the first 8 weeks of pregnancy. Subvalvular aortic stenosis defects are known to be formed during fetal development and are linked with several congenital syndromes. Structural heart imaging techniques are useful to some extent in the early diagnosis of aortic valve stenosis.

The acquired aortic stenosis segment is anticipated to hold a key share of the market, owing to the increasing cases of diabetes, high blood pressure, abnormal lipids, and chronic kidney diseases in the mid-aged population. Increasing stress levels may complicate aortic stenosis conditions which are known to be progressive disease-causing conditions.

Aortic Stenosis Market Type

Treatment Segment Analysis

On the basis of the treatment, the market is divided into transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). The transcatheter aortic valve implantation treatment technique is anticipated to rise significantly in the coming years of the forecast period, owing to the non-invasive nature of the treatment.

The recovery time for patients post transcatheter aortic valve implantation (TAVI) is less in comparison to other treatments which is expected to boost the segment. 
The surgical aortic valve replacement (SAVR) segment is anticipated to account for a major market share in the coming years, owing to the surgical nature of the treatment carried out by specialized surgeons.

For patients with high surgical risk, surgical aortic valve replacement (SAVR) is a clinically effective heart valve replacement treatment option that is expected to boost the segment during the forecast period.

Treatment Center Segment Analysis

Based on the treatment center, the aortic stenosis market is subdivided into pharmacy stores, clinics, and hospitals. The hospitals segment is expected to expand at a significant growth rate during the projection period owing to the complications involved in open surgeries that need specialization and are time-consuming.

Hospitals are well equipped with the latest technologies and highly skilled doctors to perform necessary medical tasks for taking care of suffering patients which is expected to boost the market share in the next few years.


The retail pharmacy segment is anticipated to account for a major market share in the coming years, owing to the pharmaceutical dispensing facilities of prescribed drugs and devices in moderate quantities. Drugs are stored, dispensed, and compounded with filled prescriptions effective for aortic stenosis treatments which are likely to boost the segment growth in the forecast period.

Regional Analysis

In terms of region, the global aortic stenosis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the rising cases of aortic stenosis, growing healthcare expenses, and increased awareness about aortic stenosis, in North America. Close to 5% of the total American population, is suffering from aortic stenosis who are above 85 years of age.

Asia Pacific is projected to grow at a rapid pace in the forecast period, owing to advancements in the healthcare sector of Japan, India, and China in specific. Growing government initiatives for promoting awareness about aortic stenosis and a rise in the demand for treatment options are some of the other factors expected to increase revenue in the Asia Pacific region.

Aortic Stenosis Market Region

Segments

The global aortic stenosis market has been segmented on the basis of

Type

  • Congenital
    • Subvalvular
    • Valvular
    • Supravalvular
  • Acquired Aortic Stenosis

Treatment Center

  • Pharmacy Stores
  • Clinics
  • Hospitals

End-user

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Boston Scientific Corporation
  • CryoLife, Inc.
  • JenaValve Technology, Inc.
  • Thubrikar Aortic Valve
  • Medtronic plc
  • Coroneo; Meril Life Sciences Pvt. Ltd.
  • AstraZeneca plc.
  • Abbott Laboratories
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • LifeNet Health

Competitive Landscape

Key players competing in the aortic stenosis market are Boston Scientific Corporation; CryoLife, Inc.; JenaValve Technology, Inc.; Thubrikar Aortic Valve; Medtronic plc; Coroneo Meril Life Sciences Pvt. Ltd.; AstraZeneca plc.; Abbott Laboratories; LivaNova PLC; Edwards Lifesciences Corporation; and LifeNet Health.      

These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. The competitive landscape covers key insights into growth strategies adopted by major market players.

  • In September 02, 2020, CryoLife, a leading manufacturing company of medical devices, announced the acquisition of aortic repair device developer Ascyrus Medical known for developing the world’s first aortic arch remodeling device for treating acute Type A aortic dissections. The deal was valued at up to USD 200 Mn between the giants of the medical manufacturing industry.

    Aortic Stenosis Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aortic Stenosis Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aortic Stenosis Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aortic Stenosis Market - Supply Chain
  4.5. Global Aortic Stenosis Market Forecast
     4.5.1. Aortic Stenosis Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aortic Stenosis Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Aortic Stenosis Market Absolute $ Opportunity
5. Global Aortic Stenosis Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Aortic Stenosis Market Size and Volume Forecast by Types
     5.3.1. Congenital
     5.3.2. Acquired Aortic Stenosis
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Aortic Stenosis Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Aortic Stenosis Market Size and Volume Forecast by End Users
     6.3.1. Online Pharmacy
     6.3.2. Retail Pharmacy
     6.3.3. Hospital Pharmacy
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Aortic Stenosis Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Aortic Stenosis Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Aortic Stenosis Demand Share Forecast, 2019-2026
8. North America Aortic Stenosis Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Aortic Stenosis Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Aortic Stenosis Market Size and Volume Forecast by Types
     8.4.1. Congenital
     8.4.2. Acquired Aortic Stenosis
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Aortic Stenosis Market Size and Volume Forecast by End Users
     8.7.1. Online Pharmacy
     8.7.2. Retail Pharmacy
     8.7.3. Hospital Pharmacy
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Aortic Stenosis Demand Share Forecast, 2019-2026
9. Latin America Aortic Stenosis Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Aortic Stenosis Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Aortic Stenosis Market Size and Volume Forecast by Types
     9.4.1. Congenital
     9.4.2. Acquired Aortic Stenosis
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Aortic Stenosis Market Size and Volume Forecast by End Users
     9.7.1. Online Pharmacy
     9.7.2. Retail Pharmacy
     9.7.3. Hospital Pharmacy
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Aortic Stenosis Demand Share Forecast, 2019-2026
10. Europe Aortic Stenosis Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Aortic Stenosis Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Aortic Stenosis Market Size and Volume Forecast by Types
     10.4.1. Congenital
     10.4.2. Acquired Aortic Stenosis
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Aortic Stenosis Market Size and Volume Forecast by End Users
     10.7.1. Online Pharmacy
     10.7.2. Retail Pharmacy
     10.7.3. Hospital Pharmacy
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Aortic Stenosis Demand Share Forecast, 2019-2026
11. Asia Pacific Aortic Stenosis Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Aortic Stenosis Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Aortic Stenosis Market Size and Volume Forecast by Types
     11.4.1. Congenital
     11.4.2. Acquired Aortic Stenosis
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Aortic Stenosis Market Size and Volume Forecast by End Users
     11.7.1. Online Pharmacy
     11.7.2. Retail Pharmacy
     11.7.3. Hospital Pharmacy
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Aortic Stenosis Demand Share Forecast, 2019-2026
12. Middle East & Africa Aortic Stenosis Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Aortic Stenosis Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Aortic Stenosis Market Size and Volume Forecast by Types
     12.4.1. Congenital
     12.4.2. Acquired Aortic Stenosis
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Aortic Stenosis Market Size and Volume Forecast by End Users
     12.7.1. Online Pharmacy
     12.7.2. Retail Pharmacy
     12.7.3. Hospital Pharmacy
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Aortic Stenosis Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Aortic Stenosis Market: Market Share Analysis
  13.2. Aortic Stenosis Distributors and Customers
  13.3. Aortic Stenosis Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Boston Scientific Corporation
     13.4.2. JenaValve Technology, Inc.
     13.4.3. CryoLife, Inc.
     13.4.4. Thubrikar Aortic Valve
     13.4.5. Medtronic plc
     13.4.6. Coroneo; Meril Life Sciences Pvt. Ltd.
     13.4.7. AstraZeneca plc.
     13.4.8. Abbott Laboratories
     13.4.9. LivaNova PLC
     13.4.10. Edwards Lifesciences Corporation
     13.4.11. LifeNet Health

Methodology

Our Clients

sinopec
FedEx Logistics
General Mills
Dassault Aviation
Deloitte
The John Holland Group
Siemens Healthcare
Nestle SA